American Brain Tumor Association Awards 11 Research Grants to Advance Brain Tumor Research

American Brain Tumor Association Awards 11 Research Grants to Advance Brain Tumor Research

PR Newswire

CHICAGO, Oct. 30, 2020

CHICAGO, Oct. 30, 2020 /PRNewswire/ — As the nation’s first nonprofit organization committed to funding brain tumor research and providing education and information across all tumor types, the American Brain Tumor Association (ABTA) persists in its mission, announcing today the investment of $368,000 towards 11 new research grants to foster innovation in diagnosis and treatment of brain tumors in adults and children.

American Brain Tumor Association
American Brain Tumor Association

The ABTA’s grant program plays an integral role in advancing the understanding and treatment of brain tumors. Dedicated to investing in early-stage investigators who have unique perspectives to drive the future of brain tumor science and treatment, the ABTA provides research grants to medical students, post-doctoral fellows, and early-career faculty. This investment is even more critical with the COVID-19 pandemic shifting research priorities and impacting government funding for brain tumor research.

“We are excited to continue our legacy of supporting innovative research and early-career researchers, especially during this challenging time. With almost $33 million invested to date, the ABTA is committed to funding the research that will one day lead to cures,” said Nicole Willmarth, Ph.D., chief mission officer, ABTA.

With the Southeastern Brain Tumor Foundation (SBTF) investing more than $100,000 to support three research projects, the ongoing partnership between the ABTA and SBTF exemplifies the strengths of the ABTA’s rigorous grant selection process and accelerates the research investments of both organizations.

“The vast potential of the new projects we fund and the incredible efforts by the researchers, renews my optimism that better treatments are on the horizon. Our collaborations with organizations, like SBTF, amplify our ability to achieve our common goal of improving outcomes for brain tumor patients,” said Nicole Willmarth.

This year’s slate of research investigates critical areas in neuro-oncology research including experimental therapeutics, the role of the immune system and immunotherapies, as well as factors that modify gene function in brain tumor cells.

The ABTA congratulates the 2020 grant recipients listed below. To learn more about the grant recipients and their research projects, visit https://www.abta.org/research/research-funding-impact/.

Basic Research Fellowships are two-year, $100,000 grants awarded to post-doctoral fellows who are mentored by established and nationally-recognized experts in the neuro-oncology field.

  • Emily Darrow, Ph.D., St. Jude Children’s Research Hospital

  • Tyler Miller, M.D., Ph.D., Massachusetts General Hospital

Discovery Grants are one-year, $50,000 grants supporting cutting-edge, innovative approaches that have the potential to change current diagnostic or treatment standards of care for either adult or pediatric brain tumors.

  • Munjal Acharya, Ph.D., University of California, Irvine

  • Lan Hoang-Minh, Ph.D., University of Florida

  • Gary Kohanbash, Ph.D., Children’s Hospital of Pittsburgh

Medical Student Summer Fellowships are $3,000 grants awarded to medical students to conduct brain tumor research projects under the guidance of neuro-oncology experts. Through these grants, the ABTA seeks to encourage physician-scientists to enter and remain in the brain tumor field.

  • Hasan Alrefai, B.S., University of Alabama at

Read more

VoxNeuro and The Canadian Football League Alumni Association Sign Collaboration Agreement

CFLAA Will Offer VoxNeuro’s Cognitive Health Assessments™ to Its Members

VoxNeuro and the Canadian Football League Alumni Association (CFLAA) are joining forces to offer objective cognitive assessment to CFLAA members, including Canadian football players, former CFL players, and other communities of interest. Through the partnership, these groups will also raise awareness of long term impacts of head trauma, like concussion. For ageing Canadians who have experienced head-trauma throughout their lives, a growing concern is understanding its relationship with cognitive decline.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005188/en/

Legends Luncheon with Canadian Football League Alumni Association members. Courtesy of the CFLAA.

Under the terms of the agreement, VoxNeuro and the CFLAA will collaborate to share the message that long-term effects of head-trauma, from concussion and sub-concussive blows, are prevalent, and not exclusive to athletes who have dedicated their lives to playing impact or high-risk sports. Brain injuries can happen to anyone and each injury is unique – meaning they need to be assessed and treated accordingly.

“We are excited about our collaboration with VoxNeuro. The CFLAA is committed to provide health and wellness support to our members and to the community we serve. We can only do that by aligning with like minded partners. VoxNeuro and its team are such a partner.” – Leo Ezerins, Executive Director and Founder of CFLAA

The CFLAA and VoxNeuro will introduce a significant new neurotechnology to support the health of the CFLAA’s members. The neurotechnology, which assesses cognitive function in an easily accessible clinical setting, will give guidance to providing a solution to any cognitive deficiencies the CFLAA members are experiencing.

This partnership and neurotechnology have a historical tie – VoxNeuro was founded following a breakthrough study of ex-CFL players that used the neurotechnology VoxNeuro has since advanced and made clinically available, called Cognitive Health Assessments™.

VoxNeuro’s Cognitive Health Assessments™ combine imaging and functional tests, drawing on strengths from the most trusted brain assessments used clinically today. The data provided in a patient report differentiates between true cognitive decline and perceived decline due to symptoms caused by situational factors, such as stress, general fatigue or mood.

The ability to make these differentiations is massively impactful for this patient population who are uncertain about the health of their brain, and long-term impacts they may be experiencing from historical injuries. Regardless of the time post injury, the reports help healthcare professionals create targeted plans specific to a patient’s needs and track their performance over time.

VoxNeuro’s technology is the only cognitive assessment in the world today that uses objective, quantifiable neurophysiological data to inform healthcare providers & patients with the specifics of various cognitive brain functions, such as:

  • Executive Function

  • Memory

  • Information Processing

  • Concentration

  • Attention

  • Language Comprehension

The awareness campaign will involve various speaking engagements, events and collaborations with other not-for-profit organizations focused on brain health that both groups actively collaborate with, following the mission to improve brain health across Canada.

“Many CFLAA members have experienced numerous concussive and sub-concussive blows

Read more
  • Partner links